Temple University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Temple University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Temple University: 163 sponsored US clinical trials, 21 recruiting.
Temple University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 128 completed. 18 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Temple University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
128 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 2 of 4
Chronic HBV Management for Asian American
NCT04082338
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
NCT03986762
Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis
NCT04373590
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
NCT03713645
Social Networks and Renal Education: Promoting Transplantation
NCT03536858
Snacks, Smiles and Taste Preferences
NCT03631992
Risk Communication in African American Smokers
NCT04084561
Effectiveness of Physical Therapy Interventions for Low Back Pain Targeting the Low Back Only or Low Back Plus Hips
NCT03550014
Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
NCT03707834
PrEP Communication Intervention for Female Clients of a Needle Exchange
NCT03541642
Experiential Training for Community Therapists
NCT03354975
Factors Predicting Ineffective Contraception Use
NCT03500978
Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal
NCT03186508
Foot Reflexology in Ocular Hypertensive and Glaucoma Patients
NCT04695314
Oral Health Education Interventions Among Seniors
NCT03301714
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
NCT04919317
A Randomized Controlled Trial of Trauma-awareness Training for Early Childhood Educators
NCT03303482
Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients
NCT03221387
Readmission Prevention Pilot Trial in Diabetes Patients
NCT03243383
Black Men's Care, and Intervention to Re-Engage HIV+ Black Men in Care
NCT03579251
Just-in-time Adaptive Feedback Systems to Assist Individuals With Spinal Cord Injury
NCT03773692
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT03214458
Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk
NCT02979860
Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
NCT03510351
Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis
NCT03327584
Ultrasound Guided Versus Landmark Guided Arterial Line Placement by Emergency Medicine Interns
NCT03326739
Movantik for Opioid-Related Esophageal Disorders
NCT02998606
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
NCT02563769
Health Promoters and Organ Donation
NCT04007419
Community-based Obesity Treatment in African American Women After Childbirth
NCT02829229
Liraglutide for HIV-associated Neurocognitive Disorder
NCT02743598
U01 CRC Project for Vietnamese Americans
NCT03413605
Implementation and Evaluation of an Activity Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer
NCT02802787
Smart Technology for Weight Loss and Metabolic Health
NCT02742662
Babies Living Safe and Smokefree
NCT02602288
Pilot HPV Vaccination in Chinese American Community
NCT04505930
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
NCT02326259
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
NCT02628223
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity
NCT02229708
Enhanced vs. Routine Clear Liquid Intake in Labor
NCT02524002
Undiagnosed Hepatitis C Infection in an Urban Hospital
NCT01957085
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
NCT02029976
Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization
NCT01973998
Intervention to Promote Weight Loss in Latinas At-risk for Diabetes
NCT02088034
Clinical Management of Anxiety and Access to Health Care
NCT02081365
Influence of Supportive Sandals on Y-Balance Performance on Healthy Young Individuals
NCT01908998
An Interactive Preventive Health Record to Increase Colorectal Cancer Screening
NCT01885351
Ethical, Legal, and Social Issues Substudy in Relation to the GTEx Project
NCT02887339
Sancuso® for Gastroparesis: An Open Label Study.
NCT01989221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 17 |
| Phase 3 | 5 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the Temple University pipeline
21 recruiting of 163 indexed (13% open); 128 completed (79%).
Phase mix: 18 late (III/IV) vs 25 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Temple University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Temple University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Tufts University · 163 trials · 6% recruiting
- Wayne State University · 163 trials · 13% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
- Intermountain Health Care · 13% recruiting · 85 trials
Related
What to do with this Temple University page
163 registered trials is a research-attention snapshot, not an endorsement of Temple University or any single study.
- 21 of Temple University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Temple University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Temple University pipeline card: 163 registered trials from official public datasets.Report a data error.